1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
  4. > Analysis of the Global Diabetes Drug Delivery Market : Future Options for End Users

Methodology

The analysis in this research service is based on the following:
•Information collected through discussions with market participants
•Information from secondary pharmaceutical companies, medical device companies involved in drug delivery systems, related Web sites, and other credible sources
•Public announcements from key market leaders, suppliers, new market entrants, and other companies
•Frost & Sullivan’s published research and market and technology expertise All market figures and shares listed within this report are Frost & Sullivan's assessments based on the research conducted. For Market Engineering research, Frost & Sullivan utilises tried and tested marketing techniques to provide the research structure and an easy format to compare growth across different countries and markets over a specific time period. This project uses primary (telephone) and secondary (published and online material) research as the principal methods of data gathering. Interviews for this project primarily focus on the respondent types outlined below:
•Industry participants
•End users
•Key regulatory bodies
•Frost & Sullivan published research services
•Decision Support Databases
•Country Industry Forecasts
•Annual reports published by companies

Key Findings

•In 2014, the global injectable drug delivery market was estimated to be $ x billion, of which, diabetes injectables made up x % at $ x billion.
•The global oral drug delivery market was valued at $ x billion in 2014 with oral diabetes drugs comprising x % ($ x billion).
•Injectable pens form the most attractive drug delivery sector in the diabetes drug market; major drug companies are planning to launch pipeline products between 2015 and 2020 (e.g., U x and IDegLira).
•Oral insulin and other forms of needleless drug delivery systems, such as Omarigliptin (MK-3102), Metformin Fixed Dose Combination (FDC), and Dallresp (roflumilast), are expected to enter the diabetes market by the end of 2019.
•Insulin inhalers such as Afrezza® from MannKind Corporation are expected to launch in Q1 2015. Insulin patches are under development and could become game changers in the diabetes drug delivery market.
•In 2015, four major diabetes drugs will enter the US and European markets, namely, Afrezza® (MannKind’s inhalable drug distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen).
•Depending on the acceptance of inhalable diabetes drug delivery, the global diabetes drug market can expect increased investment in the future. At present, with the exception of one inhalable drug approved by the Food and Drug Administration (FDA), there are no other inhalable products in the diabetes clinical pipeline.

Unmet Needs in the Diabetes Drug Delivery Market

Patients
•Limited drug delivery options available to patients (oral or injectable)
•Drug discontinuity in aged populations due to memory loss and reimbursement costs
•Rise in patient demand for needleless diabetes drug delivery

Providers
•Disease not under control due to poor patient-adherence to medication regimens and lack of proper disease management
•Oral insulin and other alternate forms to be available after 2 to 3 years
•Efficacy of new drug delivery systems still debatable

Payers
•Difference in insurance schemes from region to region
•Variations in price regulations in important markets

Scope and Segmentation

•This study looks at the global diabetes drug delivery market and is segmented as follows:
oInjectable diabetes drug delivery market
oOral diabetes drug delivery market
oTransdermal patches and inhalable diabetes drug delivery market*
oOther diabetes drug deliveries market (implantable devices and artificial pancreas)**
•The study is also segmented by region:
oThe United States
oEurope
oAsia-Pacific

Key Questions This Study Will Answer

Which is the most preferred diabetes drug delivery system?
What are the market trends that will impact existing diabetes drug delivery systems?
What are the key companies to watch in the upcoming years?
What are the new emerging diabetes drug delivery systems?
What are the key drivers and restraints in the diabetes drug delivery market?
Which are the main competitors in each type of diabetes drug delivery market?

Table Of Contents

Analysis of the Global Diabetes Drug Delivery Market : Future Options for End Users
Methodology 6
Executive Summary 7
• Key Findings 8
• Key Findings—Options in the Diabetes Drug Delivery Market 9
• Unmet Needs in the Diabetes Drug Delivery Market 10
• Pumps or Pens—Future Investment Opportunities for Type 1 Diabetes 11
• Scope and Segmentation 12
• Key Questions This Study Will Answer 13
• Market Engineering Measurements 14
• CEO's Perspective 15
• Key Companies To Watch 16
• 3 Key Predictions 17
Market Overview 18
• Market Background 19
• Market Segmentation 20
• Global Diabetes Drug Delivery Market—Type of Delivery Usage by Region 22
Competitive Playbook 23
• New Market Opportunities 24
• Pipeline of Diabetes Drug Delivery Systems 26
• Attractiveness in Diabetes Drug Delivery Market 27
Drivers and Restraints—Total Diabetes Drug Delivery Market 28
• Market Drivers 29
• Market Restraints 30
Forecasts and Trends—Total Diabetes Drug Delivery Market 31
• Market Engineering Measurements 32
• Forecast Assumptions 33
• Revenue Forecast 34
• Revenue Forecast by Type of Diabetes Drug Delivery 35
• Revenue Forecast Discussion 36
• Top Competitors 37
Injectable Diabetes Drug Delivery Market Analysis 38
• Market Engineering Measurements 39
• Injectable Diabetes Drug Delivery Market—Revenue Forecast 40
• Revenue Forecast Discussion 41
• Injectable Diabetes Drug Delivery Market—Competitive Assessment 42
• Promising Injectable—Once-a-Week Diabetes Drug 43
Oral Diabetes Drug Delivery Market Analysis 44
• Market Engineering Measurements 45
• Oral (Non-insulin) Diabetes Drug Delivery Market—Revenue Forecast 46
• Revenue Forecast Discussion 47
• Oral Diabetes Drug Delivery Market—Competitive Assessment 48
Inhalable Diabetes Drug Delivery Market Analysis 49
• Market Engineering Measurements 50
• Inhalable Diabetes Drug Delivery Market—Revenue Forecast 51
• Inhalable Diabetes Drug Delivery—Competitive Assessment 52
• Inhalable Drug Delivery System and Injectable Drug Delivery System 53
New Technologies and Trends in Diabetes Drug Delivery by Region 54
• The United States—New Technologies in Diabetes Drug Delivery 55
• The United States—Trends in Diabetes Drug Delivery 56
• Europe—New Technologies in Diabetes Drug Delivery 57
• Europe—Trends in Diabetes Drug Delivery 58
• APAC (India)—New Technologies in Diabetes Drug Delivery 59
• APAC (India)—Trends in Diabetes Drug Delivery Market 60
Key Companies To Watch 61
• Becton Dickinson and Company 62
• Gerresheimer Bunde 63
• Owen Mumford Ltd 64
• Zosano Pharma Corporation 65
• ViaCyte, Inc. 66
• Echo Therapeutics 67
Conclusion 68
• Conclusion 69
• Frost and Sullivan Awards 70
Appendix 72

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

North American Drug Delivery Technologies Market by Route of Administration, Pulmonary, Injectable, Ocular, Nasal, Topical, Implantable), End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The North American drug delivery technologies market is projected to reach USD 758.7 billion by 2021 from USD 520.0 billion in 2016, at a CAGR of 6.5% during the forecast period. Major factors contributing ...

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

  • $ 4995
  • Industry report
  • September 2016
  • by iData Research, Inc.

The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence ...

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

Injectable Drug Delivery Market Analysis, By Device Type, By Formulation, By Therapeutic Use, By End-user Application, By Region And Segment Forecasts From 2013 to 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global injectable drug delivery market is expected to reach USD 931.1 billion by 2024, according to a new report by Grand View Research, Inc. The increase in number of chronic diseases like diabetes ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.